{"id":4087,"date":"2026-04-10T12:49:09","date_gmt":"2026-04-10T10:49:09","guid":{"rendered":"https:\/\/www.cqssalud.com\/new-anti-obesity-drugs-that-are-also-transforming-cardiovascular-health\/"},"modified":"2026-04-10T12:49:09","modified_gmt":"2026-04-10T10:49:09","slug":"new-anti-obesity-drugs-that-are-also-transforming-cardiovascular-health","status":"publish","type":"post","link":"https:\/\/www.cqssalud.com\/en\/new-anti-obesity-drugs-that-are-also-transforming-cardiovascular-health\/","title":{"rendered":"New anti-obesity drugs that are also transforming cardiovascular health"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">For years, treating obesity with medication was a difficult task. Results were often modest, and many treatments were eventually discontinued due to side effects or limited effectiveness. That is why, when new drugs based on metabolic hormones began to be developed just over a decade ago, interest was immediate.  <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Today, these medicines \u2014 known for acting on the <\/span><b>GLP-1<\/b><span style=\"font-weight: 400;\">\u2014 are changing the clinical approach to obesity and type 2 diabetes. But what is most interesting is that researchers have begun to observe effects that go beyond weight control. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">In various clinical trials, these treatments appear to be associated also with <\/span><b>cardiovascular benefits<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><b>From Diabetes to Metabolic Treatment<\/b><\/p>\n<p><span style=\"font-weight: 400;\">These drugs were not originally developed to treat obesity, but rather diabetes. GLP-1 is a hormone released by the body after eating that helps regulate blood glucose levels. It also sends signals to the brain that contribute to the feeling of fullness.  <\/span><\/p>\n<p><span style=\"font-weight: 400;\">When researchers developed drugs capable of mimicking that hormone, they found that patients not only improved their glucose control; they also tended to eat less and lose weight. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">That discovery changed the course of clinical research. In recent years, large-scale trials have been conducted to investigate the use of these drugs specifically for the treatment of obesity. <\/span><\/p>\n<p><b>What the studies are beginning to show<\/b><\/p>\n<p><span style=\"font-weight: 400;\">The results have surprised even many researchers. In some clinical trials, patients treated with these drugs have achieved weight losses of more than ten per cent of their initial body weight. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">But the most striking findings emerged when the scientists analysed other health indicators.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Some follow-up studies have found that patients treated with GLP-1-based drugs show <\/span><b>a significant reduction in the risk of cardiovascular events<\/b><span style=\"font-weight: 400;\">, particularly in people with obesity or diabetes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The exact mechanisms behind this effect are still being investigated. Among the hypotheses being considered is that these drugs may improve blood vessel function, reduce inflammation or influence the heart\u2019s energy metabolism. <\/span><\/p>\n<p><b>A new approach to metabolic diseases<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Obesity rarely occurs on its own. It is often accompanied by high blood pressure, insulin resistance or abnormalities in lipid metabolism. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">For that reason, many specialists consider that these treatments should not be understood solely as medicines for losing weight. In fact they form part of a more comprehensive approach aimed at  <\/span><b>improve the metabolic balance of the body<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Whilst clinical trials continue, researchers are already working on a8&gt; on a new generation of drugs that combine various hormonal mechanisms with the aim of enhancing their effects.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If these findings continue to be confirmed, we may be witnessing the dawn of a new era in the treatment of metabolic diseases.<\/span><\/p>\n<p><b>Frequently Asked Questions FAQ<\/b><\/p>\n<p><b>What are the medicines GLP-1?<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">These are drugs that mimic a hormone in the gut that regulates the metabolism of of glucose and the sensation of fullness.<\/span><\/p>\n<p><b>Are they used solely for losing weight?<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Originally were developed for type 2 diabetes, although they are currently also used in the treatment of obesity.<\/span><\/p>\n<p><b>What do studies say about weight loss?<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Clinical trials have shown significant weight loss in many patients.<\/span><\/p>\n<p><b>Can they affect cardiovascular health?<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Various studies have observed a reduction in the risk of cardiovascular events in patients treated with these drugs.<\/span><\/p>\n<p><b>Are they a treatment for obesity?<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Forman parte de un abordaje m\u00e9dico integral que incluye cambios en el estilo de vida y seguimiento cl\u00ednico.<\/span><\/p>\n<p><b>Sources<\/b><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183\"><span style=\"font-weight: 400;\">https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183<\/span><\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2307563\"><span style=\"font-weight: 400;\">https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2307563<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">https:\/\/www.nature.com\/articles\/s41591-023-02637-2<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>For years, treating obesity with medication was a difficult task. Results were often modest, and many treatments were eventually discontinued due to side effects or limited effectiveness. That is why, when new drugs based on metabolic hormones began to be developed just over a decade ago, interest was immediate. Today, these medicines \u2014 known for [&#8230;]\n","protected":false},"author":1,"featured_media":4089,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[46],"tags":[],"class_list":["post-4087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cqs-en"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/posts\/4087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/comments?post=4087"}],"version-history":[{"count":0,"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/posts\/4087\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/media\/4089"}],"wp:attachment":[{"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/media?parent=4087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/categories?post=4087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cqssalud.com\/en\/wp-json\/wp\/v2\/tags?post=4087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}